Results 151 to 160 of about 20,235 (200)
Some of the next articles are maybe not open access.
Congenital Muscular Dystrophies and Congenital Myopathies
Continuum, 2013The purpose of this review is to provide information regarding the diagnosis and natural history of some very rare disorders: congenital muscular dystrophies and congenital myopathies. Patients with these conditions share characteristics such as early onset of weakness and severe hypotonia. Other organs such as the brain, eyes, and skin may be involved.
Susan T, Iannaccone, Diana, Castro
openaire +2 more sources
Congenital myopathies and congenital muscular dystrophies
Current Opinion in Neurology, 2001Congenital myopathies and congenital myopathic dystrophies are distinct groups of inherited diseases of muscle, genetically heterogeneous, that manifest in early life or infancy. Congenital myopathic dystrophy is characterized by a dystrophic pattern, whereas no necrotic or degenerative changes are present in congenital myopathies.
N, Tubridy, B, Fontaine, B, Eymard
openaire +2 more sources
Severe Congenital Muscular Dystrophy
Archives of Pediatrics & Adolescent Medicine, 1967THE history of amyotonia congenita exemplifies impressively how diagnostic inaccuracy hinders scientific progress. Lack of appropriate laboratory tests, clinical follow-ups, and pathological documentation confused the semantics of neonatal and infantile hypotonia for decades.
H, Zellweger +3 more
openaire +2 more sources
A form of congenital muscular dystrophy
Brain and Development, 1980Five children, between 2 and 10 years old, 3 boys and 2 girls, two of them siblings, showed mild clinical and morphological congenital muscular dystrophy. Neuromuscular signs and symptoms being present from birth or early infancy, aggravated only insignificantly during the course of the disease.
H H, Goebel +3 more
openaire +2 more sources
Congenital Muscular Dystrophies
Neurologic Clinics, 1988The congenital muscular dystrophies are a group of genetic myopathies characterized by hypotonia, weakness, or arthrogryposis at birth. Classification is inadequate and based entirely upon phenotypic expression, because a genetic marker has not been identified in any of these disorders.
openaire +2 more sources
A variant of congenital muscular dystrophy
Brain and Development, 2002We analyzed three Japanese patients (two boys and a girl) from two families with congenital muscular dystrophy (CMD) and brain involvement. One of the two families had two affected siblings of different sexes. Parental consanguinity was not documented in either family.
Mieko, Yoshioka +4 more
openaire +2 more sources
Congenital muscular dystrophies
2011Congenital muscular dystrophies (CMDs) are a heterogeneous group of disorders characterized by muscle weakness from birth, or shortly after, and variable clinical manifestations of the eye and central nervous system. Some of these disorders are fatal in the first years of life, whereas others have a milder course, with survival into adulthood. The CMDs
Susan E, Sparks, Diana M, Escolar
openaire +2 more sources
Congenital muscular dystrophies in China
Clinical Genetics, 2019AbstractCongenital muscular dystrophies (CMDs) are clinically and genetically heterogeneous conditions. We launched a nationwide study to determine the frequency of CMD in the Chinese population and assess the status of diagnosis and disease management for CMD in China.
Lin, Ge +38 more
openaire +2 more sources
Congenital muscular dystrophies
2001Abstract The clinical diversity of CMD is suggested by the different degrees of motor develop- mental delay, physical disability and muscle pathology, and by the variable presence of mental retardation. Most of the efforts aimed at delineating and subdividing the various CMD forms have originated from the International Consortium on CMD,
Eugenio Mercuri, Francesco Muntoni
openaire +1 more source
Merosin and congenital muscular dystrophy
Microscopy Research and Technique, 2000Merosin (also called as Laminin-2) is an isoform of laminin comprised of the alpha2, beta1 and gamma1 chains. In European populations, half of the patients with classical congenital muscular dystrophy have mutations of the LAMA2 gene (6q22-23) and present reduced or absence of laminin alpha2 chain.
Y, Miyagoe-Suzuki +2 more
openaire +2 more sources

